ARTICLE | Distillery Therapeutics
Cancer
October 27, 2016 7:00 AM UTC
Cell culture studies identified an inhibitor of the AKAP13-RHOA interaction that could help treat prostate cancer. Virtual screening of a compound library and in vitro testing of hits yielded a oxopyr...